For tens of millions of patients who battle chronic lung diseases, present-day care options are mostly limited to short-term drug and oxygen therapy. Biomedical Engineering’s Interim Department Head and Professor Keith Cook is working on innovative technologies to advance the…
Read More
Study reveals crucial details on skin-related side effects of cancer immune therapies
Immune checkpoint inhibitors, which boost the immune system’s response against tumor cells, have transformed treatment for many advanced cancers, but short-term clinical trials and small observational studies have linked the medications with various side effects, most commonly involving the skin….
Read More
Genetically engineered T cells could lead to therapies for autoimmune diseases
A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments….
Read More
Discovery of new step in how brain cells work could lead to new therapies for epilepsy
Researchers have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy. This could lead to new treatment approaches for people with drug-resistant epilepsy. The study was led by…
Read More
Study into DNA biology could impact future anti-cancer therapies
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments….
Read More
Medicare coverage varies for transgender hormone therapies
A new study has shown substantial variability in access to guideline-recommended hormone therapies for older transgender individuals insured through Medicare. The variability in Medicare coverage and out-of-pocket costs for feminizing and masculinizing therapies are detailed in an article published in…
Read More